Fate Therapeutics (NQ: FATE )
3.400
+0.010
(+0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Fate Therapeutics
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1017.jpeg)
![](https://cdn.benzinga.com/files/images/story/2012/cell_therapy_national_human_genome.jpg?width=1200&height=800&fit=crop)
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Via Benzinga
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/kristopher-roller-pc_lbssxcze-unsplash.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/valuestock_image_17.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_4679.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_338.png?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/agar-g47fbfcee3_1920.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2848.png)
![](https://imonkey-blog.imgix.net/blog/wp-content/uploads/2021/12/09215710/VNT_dec2021.png?auto=fortmat&fit=clip&expires=1670716800&width=480&height=305)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_3956.jpeg?width=720)
![](https://g.foolcdn.com/editorial/images/654255/doctor-and-patient-2.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_2627.jpeg?width=720)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_102.jpg)
![](https://g.foolcdn.com/editorial/images/640692/lab-technician-colleagues-considering-ideas-and-options.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2_2.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_101.jpeg?width=720)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_midd_637649876135700981.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_268.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_271.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_1.jpg)
![](https://g.foolcdn.com/editorial/images/640122/life-science-professionals.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-morning-market-update_11.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_187.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_200.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_365.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1556.png)
![](https://www.investors.com/wp-content/uploads/2017/11/stock-drug-opioid-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_87.jpg)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.